{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:02:43Z","timestamp":1790128963170,"version":"4.0.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s11060-025-05274-9","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T16:05:12Z","timestamp":1762877112000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Multidisciplinary review outperforms qualitative MR perfusion in distinguishing post-radiation brain metastasis recurrence versus radionecrosis"],"prefix":"10.1007","volume":"176","author":[{"given":"Allison J.","family":"Toth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Fahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seamus Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Wierzbicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G.","family":"Bowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Budhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke R. G.","family":"Pike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Smithy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon S.","family":"Imber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0930-1681","authenticated-orcid":false,"given":"Nelson S.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"issue":"1","key":"5274_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neuchi.2021.04.001","volume":"68","author":"DK Mitchell","year":"2022","unstructured":"Mitchell DK, Kwon HJ, Kubica PA, Huff WX, O\u2019Regan R, Dey M (2022) Brain metastases: an update on the multi-disciplinary approach of clinical management. Neurochirurgie 68(1):69\u201385","journal-title":"Neurochirurgie"},{"issue":"1","key":"5274_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11912-011-0203-y","volume":"14","author":"L Nayak","year":"2012","unstructured":"Nayak L, Lee EQ, Wen PY (2012) Epidemiology of brain metastases. Curr Oncol Rep 14(1):48\u201354","journal-title":"Curr Oncol Rep"},{"issue":"5","key":"5274_CR3","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1200\/JCO.21.02314","volume":"40","author":"MA Vogelbaum","year":"2022","unstructured":"Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D et al (2022) Treatment for brain metastases: ASCO-SNO-ASTRO guideline. J Clin Oncol 40(5):492\u2013516","journal-title":"J Clin Oncol"},{"issue":"8","key":"5274_CR4","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/S1470-2045(17)30414-X","volume":"18","author":"A Mahajan","year":"2017","unstructured":"Mahajan A, Ahmed S, McAleer MF, Weinberg JS, Li J, Brown P et al (2017) Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: A single-centre, randomised, controlled, phase 3 trial. Lancet Oncol 18(8):1040\u20131048","journal-title":"Lancet Oncol"},{"key":"5274_CR5","doi-asserted-by":"publisher","unstructured":"Katano A, Yamashita H (2022) Brain metastasis: recent treatment modalities and future perspectives (Review). Oncol Lett 23(6). https:\/\/www.spandidos-publications.com\/https:\/\/doi.org\/10.3892\/ol.2022.13311","DOI":"10.3892\/ol.2022.13311"},{"key":"5274_CR6","doi-asserted-by":"crossref","unstructured":"Ene CI, Abi Faraj C, Beckham TH, Weinberg JS, Andersen CR, Haider AS et al (2024) Response of treatment-naive brain metastases to stereotactic radiosurgery. Nat Commun 15(1). https:\/\/www.nature.com\/articles\/s41467-024-47998-8","DOI":"10.1038\/s41467-024-47998-8"},{"issue":"6","key":"5274_CR7","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3171\/jns.2006.104.6.907","volume":"104","author":"MA Vogelbaum","year":"2006","unstructured":"Vogelbaum MA, Angelov L, Lee SY, Li L, Barnett GH, Suh JH (2006) Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin. J Neurosurg 104(6):907\u2013912","journal-title":"J Neurosurg"},{"issue":"16suppl","key":"5274_CR8","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1200\/JCO.2025.43.16_suppl.2011","volume":"43","author":"A Aizer","year":"2025","unstructured":"Aizer A, Tanguturi SK, Benham G, Brown PD, Cagney D, Catalano PJ et al (2025) Stereotactic radiation versus hippocampal avoidance whole brain radiation in patients with 5\u201320 brain metastases: A multicenter, phase 3 randomized trial. J Clin Oncol 43(16suppl):2011\u20132011","journal-title":"J Clin Oncol"},{"issue":"6","key":"5274_CR9","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1007\/s00259-019-04628-6","volume":"47","author":"M Grkovski","year":"2020","unstructured":"Grkovski M, Kohutek ZA, Sch\u00f6der H, Brennan CW, Tabar VS, Gutin PH et al (2020) 18F-Fluorocholine PET uptake correlates with pathologic evidence of recurrent tumor after stereotactic radiosurgery for brain metastases. Eur J Nucl Med Mol Imaging 47(6):1446\u20131457","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"5274_CR10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.nec.2020.06.007","volume":"31","author":"D Lee","year":"2020","unstructured":"Lee D, Riestenberg RA, Haskell-Mendoza A, Bloch O (2020) Brain metastasis recurrence versus radiation necrosis. Neurosurg Clin N Am 31(4):575\u2013587","journal-title":"Neurosurg Clin N Am"},{"issue":"12 Suppl 2","key":"5274_CR11","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1093\/neuonc\/noad188","volume":"26","author":"ZS Mayo","year":"2024","unstructured":"Mayo ZS, Billena C, Suh JH, Lo SS, Chao ST (2024) The dilemma of radiation necrosis from diagnosis to treatment in the management of brain metastases. Neuro-Oncol 26(12 Suppl 2):S56\u2013S65","journal-title":"Neuro-Oncol"},{"issue":"3","key":"5274_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s11060-021-03790-y","volume":"153","author":"WC Newman","year":"2021","unstructured":"Newman WC, Goldberg J, Guadix SW, Brown S, Reiner AS, Panageas K et al (2021) The effect of surgery on radiation necrosis in irradiated brain metastases: extent of resection and long-term clinical and radiographic outcomes. J Neurooncol 153(3):507\u2013518","journal-title":"J Neurooncol"},{"key":"5274_CR13","doi-asserted-by":"publisher","unstructured":"Oca\u00f1a-Tienda B, P\u00e9rez-Beteta J, Molina-Garc\u00eda D, Asenjo B, Ortiz de Mendivil A, Albillo D et al (2023) Growth dynamics of brain metastases differentiate radiation necrosis from recurrence. Neuro-Oncol Adv 5(1). https:\/\/academic.oup.com\/noa\/article\/doi\/https:\/\/doi.org\/10.1093\/noajnl\/vdac179\/6883995","DOI":"10.1093\/noajnl\/vdac179\/6883995"},{"key":"5274_CR14","doi-asserted-by":"crossref","unstructured":"Upadhyay R, Elguindy ANM, Salts L, Donovan K, Sengupta S, Wang K et al (2025) Boswellia serrata for cerebral radiation necrosis after radiosurgery for brain metastases. Int J Radiat Oncol 122(5):1282\u20131291","DOI":"10.1016\/j.ijrobp.2025.02.016"},{"issue":"6","key":"5274_CR15","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1159\/000163557","volume":"86","author":"R Williamson","year":"2008","unstructured":"Williamson R, Kondziolka D, Kanaan H, Lunsford LD, Flickinger JC (2008) Adverse radiation effects after radiosurgery May benefit from oral vitamin E and Pentoxifylline therapy: A pilot study. Stereotact Funct Neurosurg 86(6):359\u2013366","journal-title":"Stereotact Funct Neurosurg"},{"issue":"1","key":"5274_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ijrobp.2006.08.009","volume":"67","author":"T Ohguri","year":"2007","unstructured":"Ohguri T, Imada H, Kohshi K, Kakeda S, Ohnari N, Morioka T et al (2007) Effect of prophylactic hyperbaric oxygen treatment for radiation-induced brain injury after stereotactic radiosurgery of brain metastases. Int J Radiat Oncol 67(1):248\u2013255","journal-title":"Int J Radiat Oncol"},{"issue":"4","key":"5274_CR17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3390\/brainsci14040321","volume":"14","author":"A Schack","year":"2024","unstructured":"Schack A, Aunan-Diop JS, Gerhardt FA, Pedersen CB, Halle B, Kofoed MS et al (2024) Evaluating the efficacy of perfusion MRI and conventional MRI in distinguishing recurrent cerebral metastasis from brain radiation necrosis. Brain Sci 14(4):321","journal-title":"Brain Sci"},{"issue":"2","key":"5274_CR18","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s11060-019-03379-6","volume":"146","author":"Y Umemura","year":"2020","unstructured":"Umemura Y, Wang D, Peck KK, Flynn J, Zhang Z, Fatovic R et al (2020) DCE-MRI perfusion predicts pseudoprogression in metastatic melanoma treated with immunotherapy. J Neurooncol 146(2):339\u2013346","journal-title":"J Neurooncol"},{"issue":"1","key":"5274_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.clinimag.2012.02.016","volume":"37","author":"RJ Young","year":"2013","unstructured":"Young RJ, Gupta A, Shah AD, Graber JJ, Chan TA, Zhang Z et al (2013) MRI perfusion in determining pseudoprogression in patients with glioblastoma. Clin Imaging 37(1):41\u201349","journal-title":"Clin Imaging"},{"issue":"7","key":"5274_CR20","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.mri.2011.04.004","volume":"29","author":"J Huang","year":"2011","unstructured":"Huang J, Wang AM, Shetty A, Maitz AH, Yan D, Doyle D et al (2011) Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling. Magn Reson Imaging 29(7):993\u20131001","journal-title":"Magn Reson Imaging"},{"issue":"1","key":"5274_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11060-009-0106-z","volume":"99","author":"K Mitsuya","year":"2010","unstructured":"Mitsuya K, Nakasu Y, Horiguchi S, Harada H, Nishimura T, Bando E et al (2010) Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery. J Neurooncol 99(1):81\u201388","journal-title":"J Neurooncol"},{"issue":"2","key":"5274_CR22","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3174\/ajnr.A1362","volume":"30","author":"RF Barajas","year":"2009","unstructured":"Barajas RF, Chang JS, Sneed PK, Segal MR, McDermott MW, Cha S (2009) Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol 30(2):367\u2013372","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"5274_CR23","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3174\/ajnr.A2582","volume":"32","author":"WB Pope","year":"2011","unstructured":"Pope WB, Hessel C (2011) Response assessment in Neuro-Oncology criteria: implementation challenges in multicenter neuro-oncology trials. Am J Neuroradiol 32(5):794\u2013797","journal-title":"Am J Neuroradiol"},{"issue":"2","key":"5274_CR24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3171\/2014.10.JNS141610","volume":"123","author":"PK Sneed","year":"2015","unstructured":"Sneed PK, Mendez J, Vemer-van den Hoek JGM, Seymour ZA, Ma L, Molinaro AM et al (2015) Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors. J Neurosurg 123(2):373\u2013386","journal-title":"J Neurosurg"},{"issue":"10","key":"5274_CR25","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1093\/neuonc\/nox090","volume":"19","author":"JL Narloch","year":"2017","unstructured":"Narloch JL, Farber SH, Sammons S, McSherry F, Herndon JE, Hoang JK et al (2017) Biopsy of enlarging lesions after stereotactic radiosurgery for brain metastases frequently reveals radiation necrosis. Neuro-Oncol 19(10):1391\u20131397","journal-title":"Neuro-Oncol"},{"key":"5274_CR26","doi-asserted-by":"publisher","unstructured":"Morabito R, Alafaci C, Pergolizzi S, Pontoriero A, Iat\u00ec G, Bonanno L et al (2019) DCE and DSC perfusion MRI diagnostic accuracy in the follow-up of primary and metastatic intra-axial brain tumors treated by radiosurgery with cyberknife. Radiat Oncol 14(1). https:\/\/ro-journal.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s13014-019-1271-7","DOI":"10.1186\/s13014-019-1271-7"},{"issue":"9","key":"5274_CR27","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1001\/jamaoncol.2022.1928","volume":"8","author":"NS Moss","year":"2022","unstructured":"Moss NS, Beal K, Tabar V (2022) Brain metastasis\u2014a distinct oncologic disease best served by an integrated multidisciplinary team approach. JAMA Oncol 8(9):1252\u20131254","journal-title":"JAMA Oncol"},{"issue":"11","key":"5274_CR28","doi-asserted-by":"publisher","first-page":"e1732","DOI":"10.1200\/OP.22.00258","volume":"18","author":"NS Moss","year":"2022","unstructured":"Moss NS, El Ahmadieh TY, Brown S, Chen J, Imber BS, Pike L et al (2022) Integrated multidisciplinary brain metastasis care reduces patient visits and shortens time to adjuvant irradiation. JCO Oncol Pract 18(11):e1732\u2013e1738","journal-title":"JCO Oncol Pract"},{"key":"5274_CR53","doi-asserted-by":"crossref","unstructured":"Sharma A, Kennedy LB, Van Swearingen AED, Ahluwalia MS, Bagley SJ, Chiang VL et al (2025) Intracranial metastases from solid tumors: Call to Action and Consensus from the Society for Neuro-Oncology and American Society of Clinical Oncology Collaborative. Neuro-Oncology, noaf226","DOI":"10.1093\/neuonc\/noaf226"},{"issue":"3","key":"5274_CR29","first-page":"605","volume":"27","author":"P Gaviani","year":"2006","unstructured":"Gaviani P, Mullins ME, Braga TA, Hedley-Whyte ET, Halpern EF, Schaefer PS et al (2006) Improved detection of metastatic melanoma by T2*-weighted imaging. AJNR Am J Neuroradiol 27(3):605\u2013608","journal-title":"AJNR Am J Neuroradiol"},{"key":"5274_CR52","doi-asserted-by":"crossref","unstructured":"Bander, ED, Yuan, M, Carnevale, JA, Reiner, AS, Panageas, KS, Postow, MA, Tabar, V, & Moss, NS (2021) Melanoma brain metastasis presentation, treatment, and outcomes in the age of targeted and immunotherapies. Cancer 127(12):2062\u20132073","DOI":"10.1002\/cncr.33459"},{"issue":"4","key":"5274_CR30","doi-asserted-by":"publisher","first-page":"e254347","DOI":"10.1001\/jamanetworkopen.2025.4347","volume":"8","author":"EJ Vaios","year":"2025","unstructured":"Vaios EJ, Shenker RF, Hendrickson PG, Wan Z, Niedzwiecki D, Carpenter D et al (2025) Symptomatic necrosis with dual immune-checkpoint Inhibition and radiosurgery for brain metastases. JAMA Netw Open 8(4):e254347","journal-title":"JAMA Netw Open"},{"key":"5274_CR56","doi-asserted-by":"crossref","unstructured":"Tringale KR, Reiner AS, Sehgal RR, Panageas K, Betof Warner AS, Postow MA, Moss NS (2023) Efficacy of immunotherapy for melanoma brain metastases in patients with concurrent corticosteroid exposure. CNS Oncol 12(1):CNS93","DOI":"10.2217\/cns-2022-0014"},{"issue":"3","key":"5274_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11060-021-03872-x","volume":"155","author":"JA Wilcox","year":"2021","unstructured":"Wilcox JA, Brown S, Reiner AS, Young RJ, Chen J, Bale TA et al (2021) Salvage resection of recurrent previously irradiated brain metastases: tumor control and radiation necrosis dependency on adjuvant re-irradiation. J Neurooncol 155(3):277\u2013286","journal-title":"J Neurooncol"},{"issue":"6","key":"5274_CR32","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/neuonc\/nov301","volume":"18","author":"V Hatzoglou","year":"2016","unstructured":"Hatzoglou V, Yang TJ, Omuro A, Gavrilovic I, Ulaner G, Rubel J et al (2016) A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation. Neuro-Oncol 18(6):873\u2013880","journal-title":"Neuro-Oncol"},{"issue":"1","key":"5274_CR33","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1186\/s12885-024-12636-5","volume":"24","author":"YH Roh","year":"2024","unstructured":"Roh YH, Park JE, Park SY, Cho YH, Kim YH, Song SW et al (2024) Assessment of imaging risks for recurrence after stereotactic radiosurgery for brain metastases (IRRaS-BM). BMC Cancer 24(1):866","journal-title":"BMC Cancer"},{"issue":"1","key":"5274_CR34","first-page":"224","volume":"41","author":"M Katsura","year":"2021","unstructured":"Katsura M, Sato J, Akahane M, Furuta T, Mori H, Abe O (2021) Recognizing radiation-induced changes in the central nervous system: where to look and what to look for. Radiogr Rev Publ Radiol Soc N Am Inc 41(1):224\u2013248","journal-title":"Radiogr Rev Publ Radiol Soc N Am Inc"},{"key":"5274_CR35","doi-asserted-by":"publisher","unstructured":"Vellayappan B, Tan CL, Yong C, Khor LK, Koh WY, Yeo TT et al (2018) Diagnosis and management of radiation necrosis in patients with brain metastases. Front Oncol 8. https:\/\/www.frontiersin.org\/article\/https:\/\/doi.org\/10.3389\/fonc.2018.00395\/full","DOI":"10.3389\/fonc.2018.00395\/full"},{"issue":"1","key":"5274_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1023\/B:NEON.0000024744.16031.e9","volume":"68","author":"CM McPherson","year":"2004","unstructured":"McPherson CM, Warnick RE (2004) Results of contemporary surgical management of radiation necrosis using frameless stereotaxis and intraoperative magnetic resonance imaging. J Neurooncol 68(1):41\u201347","journal-title":"J Neurooncol"},{"issue":"3","key":"5274_CR37","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s11060-022-04101-9","volume":"159","author":"BS Imber","year":"2022","unstructured":"Imber BS, Young RJ, Beal K, Reiner AS, Giantini-Larsen AM, Krebs S et al (2022) Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases. J Neurooncol 159(3):609\u2013618","journal-title":"J Neurooncol"},{"issue":"Suppl 4","key":"5274_CR38","doi-asserted-by":"publisher","first-page":"S209","DOI":"10.4103\/2152-7806.111298","volume":"4","author":"KR Fink","year":"2013","unstructured":"Fink KR, Fink JR (2013) Imaging of brain metastases. Surg Neurol Int 4(Suppl 4):S209\u2013S219","journal-title":"Surg Neurol Int"},{"key":"5274_CR39","doi-asserted-by":"publisher","first-page":"e453","DOI":"10.1016\/j.wneu.2023.10.079","volume":"181","author":"MM Williams","year":"2024","unstructured":"Williams MM, Sohrabi AK, Kittel CA, White JJ, Cramer CK, Lanier CM et al (2024) Delayed imaging changes 18 months or longer after stereotactic radiosurgery for brain metastases: necrosis or progression. World Neurosurg 181:e453\u2013e458","journal-title":"World Neurosurg"},{"key":"5274_CR55","doi-asserted-by":"crossref","unstructured":"Le Rhun E, Weller M, Anders C, Larkin J, Li J, Moss NS, Tawbi H, Dummer R (2024) \u201cSymptomatic\u201d melanoma brain metastases: A call for clear definitions and adoption of standardized tools. Eur J Cancer 208:114202","DOI":"10.1016\/j.ejca.2024.114202"},{"issue":"1","key":"5274_CR40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11060-015-1881-3","volume":"125","author":"ZA Kohutek","year":"2015","unstructured":"Kohutek ZA, Yamada Y, Chan TA, Brennan CW, Tabar V, Gutin PH et al (2015) Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases. J Neurooncol 125(1):149\u2013156","journal-title":"J Neurooncol"},{"issue":"8","key":"5274_CR41","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.3174\/ajnr.A5252","volume":"38","author":"N Tomura","year":"2017","unstructured":"Tomura N, Kokubun M, Saginoya T, Mizuno Y, Kikuchi Y (2017) Differentiation between treatment-induced necrosis and recurrent tumors in patients with metastatic brain tumors: comparison among 11\u00a0C-methionine-PET, FDG-PET, MR permeability imaging, and MRI-ADC\u2014preliminary results. AJNR Am J Neuroradiol 38(8):1520\u20131527","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"5274_CR42","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1093\/neuonc\/nox159","volume":"20","author":"NK Taunk","year":"2018","unstructured":"Taunk NK, Oh JH, Shukla-Dave A, Beal K, Vachha B, Holodny A et al (2018) Early posttreatment assessment of MRI perfusion biomarkers can predict long-term response of lung cancer brain metastases to stereotactic radiosurgery. Neuro-Oncol 20(4):567\u2013575","journal-title":"Neuro-Oncol"},{"issue":"1","key":"5274_CR43","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1038\/s41598-022-06881-6","volume":"12","author":"JH Kim","year":"2022","unstructured":"Kim JH, Choi JW, Kong DS, Seol HJ, Nam DH, Ryu JW et al (2022) Histopathology and surgical outcome of symptomatic treatment-related changes after gamma knife radiosurgery in patients with brain metastases. Sci Rep 12(1):3013","journal-title":"Sci Rep"},{"issue":"2","key":"5274_CR44","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11060-014-1389-2","volume":"117","author":"SK Nath","year":"2014","unstructured":"Nath SK, Sheridan AD, Rauch PJ, Yu JB, Minja FJ, Vortmeyer AO et al (2014) Significance of histology in determining management of lesions regrowing after radiosurgery. J Neurooncol 117(2):303\u2013310","journal-title":"J Neurooncol"},{"issue":"2","key":"5274_CR45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/jpm12020135","volume":"12","author":"S Gaudino","year":"2022","unstructured":"Gaudino S, Giordano C, Magnani F, Cottonaro S, Infante A, Sabatino G et al (2022) Neuro-oncology multidisciplinary tumor board: the point of view of the neuroradiologist. J Pers Med 12(2):135","journal-title":"J Pers Med"},{"issue":"1","key":"5274_CR46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3171\/2020.5.JNS201299","volume":"135","author":"AM Khalafallah","year":"2021","unstructured":"Khalafallah AM, Jimenez AE, Romo CG, Kamson DO, Kleinberg L, Weingart J et al (2021) Quantifying the utility of a multidisciplinary neuro-oncology tumor board. J Neurosurg 135(1):87\u201392","journal-title":"J Neurosurg"},{"key":"5274_CR47","doi-asserted-by":"crossref","unstructured":"Yang X, Ren H, Fu J (2021) Treatment of radiation-induced brain necrosis. Oxid Med Cell Longev 2021:4793517","DOI":"10.1155\/2021\/4793517"},{"issue":"5","key":"5274_CR48","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.ijrobp.2018.04.068","volume":"101","author":"Y Xu","year":"2018","unstructured":"Xu Y, Rong X, Hu W, Huang X, Li Y, Zheng D et al (2018) Bevacizumab monotherapy reduces radiation-induced brain necrosis in nasopharyngeal carcinoma patients: A randomized controlled trial. Int J Radiat Oncol Biol Phys 101(5):1087\u20131095","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"5274_CR49","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s11060-013-1120-8","volume":"113","author":"S Telera","year":"2013","unstructured":"Telera S, Fabi A, Pace A, Vidiri A, Anelli V, Carapella CM et al (2013) Radionecrosis induced by stereotactic radiosurgery of brain metastases: results of surgery and outcome of disease. J Neurooncol 113(2):313\u2013325","journal-title":"J Neurooncol"},{"issue":"2","key":"5274_CR50","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11060-024-04669-4","volume":"168","author":"MM Basree","year":"2024","unstructured":"Basree MM, Li C, Um H, Bui AH, Liu M, Ahmed A et al (2024) Leveraging radiomics and machine learning to differentiate radiation necrosis from recurrence in patients with brain metastases. J Neurooncol 168(2):307\u2013316","journal-title":"J Neurooncol"},{"key":"5274_CR54","doi-asserted-by":"crossref","unstructured":"McKenney, AS, Weg, E, Bale, TA, Wild, AT, Um, H, Fox, MJ et al (2022) Radiomic Analysis to Predict Histopathologically Confirmed Pseudoprogression in Glioblastoma Patients. Adv Radiat Oncol 8(1):100916","DOI":"10.1016\/j.adro.2022.100916"},{"issue":"7","key":"5274_CR51","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.3390\/cancers15072184","volume":"15","author":"L Urso","year":"2023","unstructured":"Urso L, Bonatto E, Nieri A, Castello A, Maffione AM, Marzola MC et al (2023) The role of molecular imaging in patients with brain metastases: A literature review. Cancers 15(7):2184","journal-title":"Cancers"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05274-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05274-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05274-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:03:05Z","timestamp":1767704585000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05274-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5274"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05274-9","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The institutional review board (IRB #16-1531) granted this study a waiver of consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"SMR, AJT, TF, SYW, MW, SGB, JAB, LRP, JWS declare that they have no financial interest. B.S.I reports research grants (to institution) from Novartis, Kazia Therapeutics, GT Medical Technologies, AstraZeneca, and Bayer outside the submitted work and serves as a consultant to GT Medical Technologies. R.J.Y consults for Agios, Puma, NordicNeuroLab, Icon, and has a grant funding from Agios. N.S.M has research funding (to institution) from AstraZeneca, Amgen, GT Medical Technologies, and consult for Daiichi Sankyo, Kendle Healthcare, and GLG.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}